Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy

被引：0
|
作者：
Li Zhang
Yang Zhang
Pei-Yu Huang
Fei Xu
Pei-Jian Peng
Zhong-Zhen Guan
机构：
[1] Cancer Center of Sun Yat-Sen University,Department of Medical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Gemcitabine; Nasopharyngeal carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：33 / 38
页数：5
相关论文
共 50 条
  • [1] Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy
    Zhang, Li
    Zhang, Yang
    Huang, Pei-Yu
    Xu, Fei
    Peng, Pei-Jian
    Guan, Zhong-Zhen
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 33 - 38
  • [2] Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy
    Peng, PeiJian
    Ou, XueQing
    Liao, Hai
    Liu, YuMeng
    Wang, SiYang
    Cheng, ZhiBin
    Lin, Zhong
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (03) : 153 - 159
  • [3] A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
    You, Benoit
    Le Tourneau, Christophe
    Chen, Eric X.
    Wang, Lisa
    Jarvi, Andrea
    Bharadwaj, Rikki R.
    Kamel-Reid, Suzanne
    Perez-Ordonez, Bayardo
    Mann, Vijay
    Siu, Lillian L.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 255 - 260
  • [4] Phase II study of gemcitabine single agent for patients with advanced nasopharyngeal carcinoma (NPC) who failed to first line platinum-based chemotherapy.
    Zhang, L
    Guan, ZZ
    Zhang, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 516S - 516S
  • [5] A phase II trial of erlotinib after gemcitabine plus platinum-based chemotherapy in patients (pts) with recurrent and/or metastatic nasopharyngeal carcinoma (NPC)
    You, B.
    Le Tourneau, C.
    Chen, E. X.
    Chin, S. F.
    Wang, L.
    Jarvi, A.
    Bharadwaj, R. R.
    Kamel-Reid, S.
    Perez-Ordonez, B.
    Siu, L. L.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 478 - 479
  • [6] A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
    Chua, DTT
    Sham, JST
    Au, GKH
    [J]. ORAL ONCOLOGY, 2003, 39 (04) : 361 - 366
  • [7] Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
    Chen, Cui
    Wang, Feng-hua
    Wang, Zhi-qiang
    An, Xin
    Luo, Hui-yan
    Zhang, Le
    Chen, Yong-chang
    Xu, Rui-hua
    Li, Yu-hong
    [J]. ORAL ONCOLOGY, 2012, 48 (11) : 1146 - 1151
  • [8] A phase II trial of gefitinib in recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
    Chua, D. T.
    Sham, J.
    Au, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: An open-label phase II study.
    Lu, Nian
    Jiang, Yao-Fei
    Xia, Weixiong
    Huang, Ying
    Xie, Chuan-Miao
    Xu, Cheng
    Ye, Yan-Fang
    Liu, Guo-Ying
    Bei, Wei-Xin
    Ke, Liang-Ru
    Li, Wang-Zhong
    Wang, Xin
    Xie, Changqing
    Liang, Hu
    Xiang Yanqun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Tetsuro Kodama
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 189 - 195
12345